Dynamic Optical Coherence Tomography Monitoring of Keloid Laser Treatment: A Single-Case Proof-of-Concept Study
Optics · 04.02.2026 · 7 (1) · 13
DOI: 10.3390/opt7010013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Optics, online erschienen am 04.02.2026. Verfasst von Luca Guarino und 7 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Keloids are fibroproliferative scars with a prominent vascular component, and pulsed dye laser (PDL) is an established treatment, but objective imaging biomarkers of response are lacking.
Objective
To evaluate whether dynamic optical coherence tomography (D-OCT) can provide quantitative, depth-resolved monitoring of keloid vascular remodeling under PDL and to explore candidate metrics for hypothesis-generating assessment in future studies.
Methods
We conducted a prospective single-case pilot, hypothesis-generating study of a thoracic keloid treated with three sessions of 595 nm PDL, acquiring D-OCT scans at baseline and approximately 30, 60, and 90 days over a standardized 4 × 4 mm region of interest at 0.15, 0.30, and 0.50 mm depths. Primary D-OCT metrics included vascular en-face area, vessel length density, junction density, and mean vessel caliber.
Results
The superficial layer (0.15 mm) showed an almost complete collapse of vascular signal (area −88% vs. baseline), the intermediate layer at 0.30 mm exhibited a sustained ~39% reduction in vascular area with parallel decreases in length and caliber at stable branching, and the deep layer at 0.50 mm showed modest area changes with longer but thinner vessels. These depth-resolved changes were consistent with clinical improvement in Vancouver Scar Scale and POSAS scores.
Conclusions
D-OCT yielded quantitative, clinically interpretable vascular metrics that align with the expected effects of PDL in this single patient. In this patient, the percentage reduction in vascular area at 0.30 mm by week 8 emerged as a candidate quantitative metric for response monitoring; thresholds in the order of ≥25% could be tested prospectively as hypothesis-generating cut-offs in future controlled and reliability-tested studies, but are not proposed here as validated clinical criteria.
Zitieren
APA
Guarino, L., Cannarozzo, G., Gargano, L., Zappia, E., Clementi, A., Sannino, M., Pellacani, G., & Nisticò, S. P. (2026). Dynamic Optical Coherence Tomography Monitoring of Keloid Laser Treatment: A Single-Case Proof-of-Concept Study. Optics, 7(1), 13. https://doi.org/10.3390/opt7010013
Vancouver
Guarino L, Cannarozzo G, Gargano L, Zappia E, Clementi A, Sannino M, et al. Dynamic Optical Coherence Tomography Monitoring of Keloid Laser Treatment: A Single-Case Proof-of-Concept Study. Optics. 2026;7(1):13. doi:10.3390/opt7010013
BibTeX
@article{Guarino2026,
author = {Guarino, Luca and Cannarozzo, Giovanni and Gargano, Luca and Zappia, Elena and Clementi, Alessandro and Sannino, Mario and Pellacani, Giovanni and Nisticò, Steven Paul},
title = {Dynamic Optical Coherence Tomography Monitoring of Keloid Laser Treatment: A Single-Case Proof-of-Concept Study},
journal = {Optics},
year = {2026},
volume = {7},
number = {1},
pages = {13},
doi = {10.3390/opt7010013}
}
EUVIMED